Heptares Therapeutics Ltd. has spun out of the MRC Laboratory of Molecular Biology in Cambridge, with an undisclosed amount of seed funding from MVM Life Science Partners. Heptares plans to apply structural knowledge of G-protein coupled receptors) to the design and development of its own drug molecules. www.mrc.ac.uk
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
Copyright PEI Media
Not for publication, email or dissemination
Share with other subscribers
Only logged in subscribers of this site will be able to access the shared article.